ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia (2022)
- Authors:
- USP affiliated authors: LACCHINI, FERNANDA BORCHERS COELI - FMRP ; LACCHINI, RICCARDO - EERP ; CAVALLI, RICARDO DE CARVALHO - FMRP ; SANDRIM, VALÉRIA CRISTINA - FMRP
- Unidades: FMRP; EERP
- DOI: 10.2217/pgs-2022-0079
- Subjects: POLIMORFISMO; HIPERTENSÃO; ÓXIDO NÍTRICO; NITRITOS; FARMACOGENÉTICA; PRÉ-ECLÂMPSIA
- Keywords: ARG2; Arginase 2; Genetic polymorphisms; Hypertension; Nitric oxide; Nitrite; Pharmacogenetics; Preeclampsia
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmacogenomics
- ISSN: 1462-2416
- Volume/Número/Paginação/Ano: v. 23, n. 13, p. 713-722, 2022
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
LUIZON, Marcelo Rizzatti et al. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 23, n. 13, p. 713-722, 2022Tradução . . Disponível em: https://doi.org/10.2217/pgs-2022-0079. Acesso em: 31 mar. 2026. -
APA
Luizon, M. R., Pinto-Souza, C. C., Coeli-Lacchini, F. B., Lacchini, R., Cavalli, R. de C., & Sandrim, V. C. (2022). ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 23( 13), 713-722. doi:10.2217/pgs-2022-0079 -
NLM
Luizon MR, Pinto-Souza CC, Coeli-Lacchini FB, Lacchini R, Cavalli R de C, Sandrim VC. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2022 ; 23( 13): 713-722.[citado 2026 mar. 31 ] Available from: https://doi.org/10.2217/pgs-2022-0079 -
Vancouver
Luizon MR, Pinto-Souza CC, Coeli-Lacchini FB, Lacchini R, Cavalli R de C, Sandrim VC. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2022 ; 23( 13): 713-722.[citado 2026 mar. 31 ] Available from: https://doi.org/10.2217/pgs-2022-0079 - Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia
- Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia
- Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women
- Resveratrol and grape juice: effects on redox status and nitric oxide production of endothelial cells in in vitro preeclampsia model
- Circulating levels of tissue inhibitor of metalloproteinase 3, a protein with inhibitory effects on angiogenesis, are increased in pre‐eclampsia
- Preeclampsia and gestational hypertension: biochemical and antioxidant features in vitro might help understand different outcomes
- Markers of endothelial dysfunction are attenuated by resveratrol in preeclampsia
- SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia
- Effects of ADIPOQ SNPS on adiponectin levels in hypertensive disorders of pregnancy
- Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003136816.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
